Osteopontin as a multifaceted driver of bone metastasis and drug resistance.
作者： Xiaocong Pang , Kan Gong , Xiaodan Zhang , Shiliang Wu , Yimin Cui
DOI: 10.1016/J.PHRS.2019.04.030
关键词:
摘要: … This review mainly provides an insight into the function of OPN in bone microenvironment, tumor angiogenesis, drug resistance, and the downstream signaling pathways mediated by …
sci-hub.se 参考文章(137)
Anders Sundan, Magne Borset, Therese Standal, Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Experimental Oncology. ,vol. 26, pp. 179- 184 ,(2004)
Won-Young Cho, Seong-Ho Hong, Bijay Singh, Mohammad Ariful Islam, Somin Lee, Ah Young Lee, Nomundelger Gankhuyag, Ji-Eun Kim, Kyeong-Nam Yu, Kwang-Ho Kim, Young-Chan Park, Chong-Su Cho, Myung-Haing Cho, Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA. European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 94, pp. 450- 462 ,(2015) , 10.1016/J.EJPB.2015.06.017
Morse Faria, Matthew S. Halquist, Moucun Yuan, William Mylott, Rand G. Jenkins, H. Thomas Karnes, Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC–MS/MS Journal of Chromatography B. ,vol. 1001, pp. 156- 168 ,(2015) , 10.1016/J.JCHROMB.2015.05.040
Jeffrey W. Pollard, Tumour-educated macrophages promote tumour progression and metastasis Nature Reviews Cancer. ,vol. 4, pp. 71- 78 ,(2004) , 10.1038/NRC1256
Xue Hou, Xuan Wu, Peiyu Huang, Jianhua Zhan, Ting Zhou, Yuxiang Ma, Tao Qin, Rongzhen Luo, Yanfen Feng, Ying Xu, Likun Chen, Li Zhang, Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma International Journal of Cancer. ,vol. 137, pp. 1672- 1678 ,(2015) , 10.1002/IJC.29540
J. Martin Brown, Laura D. Attardi, The role of apoptosis in cancer development and treatment response Nature Reviews Cancer. ,vol. 5, pp. 231- 237 ,(2005) , 10.1038/NRC1560
Gabriele Carlinfante, Daphne Vassiliou, Olle Svensson, Mikael Wendel, Dick Heinegård, Göran Andersson, Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clinical & Experimental Metastasis. ,vol. 20, pp. 437- 444 ,(2003) , 10.1023/A:1025419708343
Guangwen Ren, Mark Esposito, Yibin Kang, Bone metastasis and the metastatic niche Journal of Molecular Medicine. ,vol. 93, pp. 1203- 1212 ,(2015) , 10.1007/S00109-015-1329-4
Yu-Chen Lee, Song-Chang Lin, Guoyu Yu, Chien-Jui Cheng, Bin Liu, Hsuan-Chen Liu, David H. Hawke, Nila U. Parikh, Andreas Varkaris, Paul Corn, Christopher Logothetis, Robert L. Satcher, Li-Yuan Yu-Lee, Gary E. Gallick, Sue-Hwa Lin, Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer Cancer Research. ,vol. 75, pp. 4949- 4959 ,(2015) , 10.1158/0008-5472.CAN-15-1215
Kosuke Mizutani, Sudha Sud, Natalie A. McGregor, Gari Martinovski, Brandon T. Rice, Matthew J. Craig, Zachary S. Varsos, Hernan Roca, Kenneth J. Pienta, The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment Neoplasia. ,vol. 11, pp. 1235- 1242 ,(2009) , 10.1593/NEO.09988